Mandate

Vinge advises Acrinova AB (publ) in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Acrinova AB (publ) (“Acrinova” or the “Company”) in connection with the Company’s uplisting to Nasdaq Stockholm. The prospectus was published on 9 December 2022 and trading on Nasdaq Stockholm commenced on 16 December 2022.

Acrinova is a real estate group with a focus on southern Sweden and on commercial properties. The Company offers comprehensive services as owner, manager and developer of real estate. Acrinova has its headquarter in Malmö, Sweden. The Company is uplisting from Nasdaq First North Premier Growth Market, where the Company's shares have been listed since 2019.

Vinge’s team has primarily consisted of Linnéa Sellström, Emma Brolund, Lorin Arabi and Michaela Ådén (Capital Markets and Public M&A), as well as Victor Ericsson, Emelie Svanberg and Maja Prahl (Corporate Tax).

 

Related

Vinge has advised Oncopeptides in connection with a directed share issue

Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026

Vinge has advised Orexo in connection with its rights issue

Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026